Page 7 - Rafael Holdings Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Rafael holdings inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Rafael Holdings Inc Today - Breaking & Trending Today

Cyclo Therapeutics Announces Execution of Definitive Agreement with Rafael Holdings, Inc. Providing for $5.0 Million of Additional Funding Via a Private Placement

Cyclo Therapeutics, Inc. , a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families living with diseases, today. | June 5, 2023 ....

United States , William Conkling , Rafael Holdings Inc , Rafael Pharmaceuticals Inc , Company Trappsol , Rafael Holdings , Cornerstone Pharmaceuticals Inc , Cyclo Therapeutics Inc , Cyclo Therapeutics , Nasdaq Listing Rules , Chief Executive Officer , Cyclo Therapeutic , Securities Act , Cornerstone Pharmaceuticals , Expanded Access , Nc Stock Exchange , Press Release , Ith Rfl Us75062e1064 ,

Rafael : On June 1, 2023, Rafael Holdings, Inc. (the "Company") entered into a Securities Purchase Agreement (the "Purchase Agreement") with Cyclo Therapeutics, Inc., a Nevada corporation ("Cyclo"). Pursuant to the Purchase Agreement, the Company will purchase 4,000,000 shares of common stock (the "Shares"), and a warrant to purchase an additional 4,000,000 Shares (the "Warrant"), for an aggregate purchase price of $5,000,000. The Warrant has an ex

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

. | June 5, 2023 ....

United States , New Jersey , William Conkling , New York Stock Exchange , York Stock Exchange , Rafael Holdings Inc , Cyclo Therapeutics Inc , Nasdaq Stock Market Inc , Securities Exchange , Exchange Commission , Commission File Number , Securities Exchange Act , Zip Code , General Instruction , Securities Act , Exchange Act , Rafael Holdings , Securities Purchase Agreement , Cyclo Therapeutics , Purchase Agreement , Listing Rule , Nasdaq Stock Market , Registration Rights Agreement , Chief Executive Officer , Annual Meeting , Nc Stock Exchange ,

Cyclo Therapeutics Announces Execution of Definitive Agreement with Rafael Holdings, Inc. Providing

GAINESVILLE, Fla. (BUSINESS WIRE) Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families living with diseases, today announced that it has entere. ....

United States , William Conkling , Jenene Thomas , Rafael Holdings , Exchange Commission , Cornerstone Pharmaceuticals Inc , Rafael Pharmaceuticals Inc , Rafael Holdings Inc , Company Trappsol , Cyclo Therapeutics Inc , Cyclo Therapeutics , Nasdaq Listing Rules , Chief Executive Officer , Cyclo Therapeutic , Securities Act , Cornerstone Pharmaceuticals , Expanded Access ,

Rafael (NYSE:RFL) Stock Price Up 1.6%

Rafael Holdings, Inc. (NYSE:RFL – Get Rating)’s stock price traded up 1.6% during mid-day trading on Monday . The stock traded as high as $1.95 and last traded at $1.93. 8,592 shares changed hands during trading, a decline of 86% from the average session volume of 59,963 shares. The stock had previously closed at $1.90. […] ....

Rafael Pharmaceuticals , Susquehanna International Group , Renaissance Technologies , Rafael Holdings Inc , Charles Schwab Investment Management Inc , Lipomedix Pharmaceuticals , Geode Capital Management , Rafael Holdings , Get Rating , Capital Management , International Group , Charles Schwab Investment Management , Real Estate , Rafael Daily ,

Cyclo Therapeutics Provides Business Update and Reports First Quarter 2023 Financial Results

Company on track to complete enrollment in ongoing pivotal Phase 3 global study evaluating Trappsol® Cyclo™ for Niemann-Pick Disease Type C1 by year end 2023

. | May 15, 2023 ....

United States , William Conkling , Rafael Holdings Inc , Company Board , Company Trappsol , Company Phase , Rafael Holdings , Cyclo Therapeutics Inc , Cyclo Therapeutics , Chief Executive Officer , Financial Results , First Quarter , Expanded Access , Nc Stock Exchange , Press Release , Nd Rfl Us75062e1064 ,